|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expenses): | ||
| Interest expense | ||
| Debt discount amortization | ||
| Financing costs | ||
| Gain on settlement of accounts payable | ||
| Interest income | ||
| Total other income (expenses) | ||
| NET LOSS | ||
| BASIC LOSS PER COMMON SHARE | ||
| DILUTED LOSS PER COMMON SHARE | ||
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC | ||
| WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED |
Loading...
